Freenome, Inc. - Common stock (FRNM)

12.00
+0.38 (3.27%)
NASDAQ· Last Trade: Aug 12th, 1:12 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close11.62
Open11.72
Bid12.00
Ask12.30
Day's Range11.52 - 12.30
52 Week Range9.970 - 14.26
Volume1,060,687
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume795,060

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026